Heather Bryant is the Vice-President, Cancer Control, at the Canadian Partnership Against Cancer (CPAC). CPAC has been funded by Health Canada since 2007 to implement a cancer control strategy across Canada, in partnership will the many organizations who provide care and leadership in a number of jurisdictions across the country. Dr. Bryant is responsible for leadership of the population health, clinical, and person-centred experience portfolios, and she and her teams have worked with partners across Canada to develop the first pan-Canadian reports on the functioning of the cancer control system.
Dr. Bryant studied medicine at the University of Calgary and took her first residency certification in family medicine. She followed this with a fellowship in community medicine and a PhD in epidemiology. Prior to joining CPAC in 2008, Dr. Bryant was Vice-President and Chief Information Officer and Director of the Division of Population Health and Information at the Alberta Cancer Board. Here she was responsible for the cancer registry, screening and prevention programs, as well as an active research unit in cancer epidemiology and prevention. In addition, she led electronic health record implementation.
Dr. Bryant has been active on many national committees and chaired the national committee for the Canadian Breast Cancer Screening Initiative (Health Canada), the joint advisory committee on cancer control (National Cancer Institute of Canada) and the population health committee (Medical Research Council). She was the inaugural chair of the Institute Advisory Board for Cancer for the Canadian Institutes for Health Research, and the National Colorectal Cancer Screening Network. Dr. Bryant is also a Clinical Professor in the departments of Community Health Sciences and Oncology at the University of Calgary.
Dr. Bryant is actively involved in international initiatives including the Union for International Cancer Control (UICC), a network of member organizations to help the global health community accelerate the fight against cancer. In 2012, Dr. Bryant was elected to the UICC Board of Directors. She co-chaired the scientific programme committee for the UICC’s World Cancer Congress held in Montreal in 2012 and is co-chair the Congress in Melbourne, Australia in December 2014.
Abstracts this author is presenting: